Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the Gastroesophageal Reflux Disease (GERD) market right now?
The market size of gastroesophageal reflux disease (GERD) has seen a slight increase in the previous years. There is an expected rise from $5.25 billion in 2024 to $5.35 billion in 2025, with a 2.0% compound annual growth rate (CAGR). This upswing during the historical timeframe can be ascribed to alterations in lifestyle and food habits, the obesity crisis, increased awareness of GERD therapies, the pharmaceutical industry’s globalization, and investments into GERD treatments.
How fast Is the gastrointestinal stromal tumor market expected to grow, and what’s its future value?
In the foreseeable future, the market size of the gastroesophageal reflux disease (GERD) is anticipated to witness consistent growth, expanding to $5.94 billion in 2029 with a compound annual growth rate (CAGR) of 2.7%. Factors contributing to this growth in the projection period include an aging demographic, increased healthcare expenditure, the rise of biomarkers, extensive GERD screening programs, a growing number of heartburn cases, and a rise in the demand for medical equipment. The period will also witness significant trends such as advancements in diagnostics and surgeries, the emergence of targeted therapies, and the integration of telehealth services.
Get your gastroesophageal reflux disease (gerd) market report here!
What are the leading drivers of growth in the gastroesophageal reflux disease (gerd) market?
The increase in esophageal disease cases is anticipated to drive the growth of the gastroesophageal reflux disease (GERD) market. Esophageal diseases, which include disorders affecting the muscular tube that links the mouth and the stomach, often require treatments that can reduce symptoms, enhance the quality of life, and prevent further complications. Such treatments tend to improve the overall health and wellbeing of those suffering from gastroesophageal reflux disease. For example, around 21,560 new esophageal cancer cases are recorded annually in the United States, with esophageal cancer accounting for 16,120 deaths, according to the American Cancer Society in January 2023. Indeed, this rising frequency of esophageal diseases boosts the growth of the gastroesophageal reflux disease (GERD) market.
Expansion of the Gastroesophageal Reflux Disease (GERD) Market Driven by Alcohol Consumption
What are the key segments defining the gastroesophageal reflux disease (gerd) market?
The gastroesophageal reflux disease (GERD) market covered in this report is segmented –
1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist, EndoCinch, Stretta, EsophyX, Transoral Incisionless Fundoplication (TIF)
2) By Procedure: Invasive, Minimally Invasive
3) By End-Users: Hospital, Homecare, Specialty Clinics
Subsegments:
1) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide
2) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
3) By H2 Receptor Blockers: Ranitidine, Famotidine, Nizatidine, Cimetidine
4) By Prokinetic Agents: Metoclopramide, Domperidone
5) By Dopamine Receptor Antagonists: Prochlorperazine, Droperidol
6) By EndoCinch: Endoscopic Suturing Systems
7) By Stretta: Radiofrequency Ablation Systems
8) By EsophyX: Transoral Fundoplication Systems
9) By Transoral Incisionless Fundoplication (TIF): TIF Devices And Systems
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12917&type=smp
Who are the key players steering the development of the gastroesophageal reflux disease (gerd) market?
Major companies operating in the gastroesophageal reflux disease (GERD) market are GlaxoSmithKline PLC, SRS Life Sciences, Johnson & Johnson Services Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Reckitt Benckiser Group PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC, Teva Pharmaceuticals, HK inno.N Corporation, Sebela Pharmaceuticals, Mylan N.V., Bausch Health Companies Inc., Johnson & Johnson MedTech, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc., Almirall S.A., HK inno.N Corporation, SRS Life Sciences Pte. Ltd.
What emerging trends are influencing the growth of the gastroesophageal reflux disease (gerd) market?
Major firms in the gastroesophageal reflux disease (GERD) sector are focusing on the development of innovative GERD treatment devices to maintain their market presence. For example, a US-based medical technology company named Laborie Medical Technologies launched a novel device called the alpHaONE wireless pH-capsule reflux testing diagnostic system for diagnosing GERD, in April 2023. This system, which provides monitoring data for up to 96 hours, boasts a compact design with bigger buttons and a foolproof capsule delivery system. Enhanced user experience is ensured with a software application having a virtual instruction program and customizable symptom buttons.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12917
Which regions are most influential in expanding the gastroesophageal reflux disease (gerd) market?
North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastroesophageal reflux disease (GERD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Inflammatory Bowel Disease Treatment Global Market Report 2024
Digestive Health Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digestive-health-global-market-report
Digestive Health Supplements Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digestive-health-supplements-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
